2024-11-17 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Report

**1. Performance vs. S&P 500 (VOO):**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits programs, including medical, dental, and vision plans.

The cumulative return of UNH is 202.7%, while the S&P 500 (VOO) shows a cumulative return of 123.86%.  Therefore, UNH outperformed the S&P 500 by 78.84 percentage points as of the last day of the provided data.  The relative outperformance, considering the historical range of the difference, is at the 49.79th percentile.

**Alpha and Beta Analysis:**

The provided data shows consistent alpha above 0 (except for the most recent period), indicating UNH has generally outperformed the market (S&P500) during the analyzed periods. Beta values generally hover around 0.9-1.1, suggesting similar volatility to the market, though it decreased to 0.5 in the most recent period.  Market capitalization has steadily increased over the years.

| Year       | CAGR     | MDD (%) | Alpha  | Beta  | Cap(B) |
|------------|----------|---------|--------|--------|---------|
| 2015-2017  | 129.6%   | 12.2%   | 91.2%  | 0.9    | 202.9   |
| 2016-2018  | 123.9%   | 18.6%   | 91.6%  | 0.9    | 229.3   |
| 2017-2019  | 90.5%    | 21.0%   | 38.8%  | 0.9    | 270.6   |
| 2018-2020  | 66.1%    | 35.3%   | 18.8%  | 1.1    | 322.7   |
| 2019-2021  | 116.2%   | 35.3%   | 16.1%  | 1.0    | 462.1   |
| 2020-2022  | 89.2%    | 35.3%   | 65.6%  | 0.9    | 487.9   |
| 2021-2023  | 57.0%    | 16.3%   | 22.1%  | 0.5    | 484.5   |
| 2022-2024  | 22.6%    | 18.8%   | -5.3%  | 0.5    | 545.9   |


**2. Recent Price Movement:**

* Closing Price: 592.23
* 5-Day Moving Average: 606.23
* 20-Day Moving Average: 581.38
* 60-Day Moving Average: 583.88

The stock price is currently below its 5-day and 60-day moving averages, suggesting a potential short-term downward trend.  However, it is above the 20-day moving average indicating some short-term support.


**3. Technical Indicators:**

* RSI: 61.36 (Slightly above neutral; not overbought)
* PPO: 0.44 (Positive, suggesting bullish momentum)
* Relative Strength Change (20-day): 6.64 (+), indicating short-term upward momentum.

The price of 592.12 is not significantly different from the closing price to warrant a discussion of rapid price changes.


**Expected Return:** A 36.83% expected return is projected over the long term (2+ years) relative to the S&P 500. This highlights the potential for outperformance, but this is just a projection and not a guarantee.


**4. Recent Financial Performance:**

| Date       | EPS      | Revenue       |
|------------|----------|---------------|
| 2024-11-04 | 6.56     | $100.82 B     |
| 2024-08-09 | 4.58     | $98.86 B     |
| 2024-05-09 | -1.53    | $99.80 B     |
| 2023-11-06 | 6.31     | $92.36 B     |
| 2024-11-04 | 6.31     | $92.36 B     | *(Duplicate entry)*


Revenue has been relatively stable, although EPS shows significant fluctuations.  The most recent EPS of 6.56 needs to be compared to analyst estimates to assess whether the result exceeded, met, or fell short of expectations.  Further analysis is needed for a more comprehensive understanding.  The negative EPS in May 2024 requires investigation into the underlying causes.


**6. Financial Information:**

**1) Revenue and Profitability:**

Revenue remains fairly consistent, with profit margins generally above 20%. A slight dip is visible in Q3 2023.  Further investigation is needed to understand the specific drivers of profitability across quarters.


| Quarter     | Revenue     | Profit Margin |
|-------------|-------------|----------------|
| 2024-09-30  | $99.18B     | 21.56%         |
| 2024-06-30  | $97.86B     | 21.52%         |
| 2024-03-31  | $98.78B     | 22.26%         |
| 2023-12-31  | $93.25B     | 22.33%         |
| 2023-09-30  | $91.36B     | 24.51%         |

**2) Capital and Profitability:**

ROE shows volatility, ranging from a negative value to above 6%.  This warrants further examination to understand the underlying reasons for such variation.

| Quarter     | Equity      | ROE (%)        |
|-------------|-------------|----------------|
| 2024-09-30  | $94.53B     | 6.41%          |
| 2024-06-30  | $89.36B     | 4.72%          |
| 2024-03-31  | $86.69B     | -1.63%         |
| 2023-12-31  | $88.76B     | 6.15%          |
| 2023-09-30  | $84.49B     | 6.91%          |


**7. News and Recent Issues:**

* **Analysis of Recent News (Shacknews, Finbold, etc.):**  This section requires access to real-time news sources to provide an accurate summary of recent news, earnings releases, and analyst opinions within the last two days.  Specific articles from these sources will be needed to provide a complete analysis.  Information on whether the recent earnings announcement met or exceeded expectations is crucial.


**8. Overall Analysis:**

UNH has demonstrated strong historical performance, consistently outperforming the S&P 500.  While recent price action shows some short-term weakness, the long-term outlook, supported by generally positive technical indicators and a projected high expected return, remains favorable.  However, significant volatility in EPS and ROE warrants deeper investigation into the underlying factors affecting these key metrics.  Access to recent news, analyst reports, and a comparison of the most recent earnings report to analyst expectations are crucial for a complete and up-to-date assessment.


**9. Disclaimer:** This report is based on the limited data provided.  It is not financial advice.  Conduct thorough independent research before making any investment decisions.
